HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Buck E Rogers Selected Research

Ligands

6/202268Ga-Labeled Benzothiazole Derivatives for Imaging Aβ Plaques in Cerebral Amyloid Angiopathy.
3/2022Neutral Ligands as Potential 64Cu Chelators for Positron Emission Tomography Imaging Applications in Alzheimer's Disease.
1/2022A comparison of 64Cu-labeled bi-terminally PEGylated A20FMDV2 peptides targeting integrin ανβ6.
11/2018Preliminary evaluation of a novel 18F-labeled PARP-1 ligand for PET imaging of PARP-1 expression in prostate cancer.
4/2016Metabolically Stabilized (68)Ga-NOTA-Bombesin for PET Imaging of Prostate Cancer and Influence of Protease Inhibitor Phosphoramidon.
2/2015Rerouting the metabolic pathway of (18)F-labeled peptides: the influence of prosthetic groups.
6/2014Development of a Radiolabeled Irreversible Peptide Ligand for PET Imaging of Vascular Endothelial Growth Factor.
7/2012Positron-emission tomography (PET) imaging agents for diagnosis of human prostate cancer: agonist vs. antagonist ligands.
1/2008Agonist-antagonist dilemma in molecular imaging: evaluation of a monomolecular multimodal imaging agent for the somatostatin receptor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Buck E Rogers Research Topics

Disease

46Neoplasms (Cancer)
06/2022 - 02/2002
12Prostatic Neoplasms (Prostate Cancer)
06/2022 - 07/2003
6Alzheimer Disease (Alzheimer's Disease)
03/2022 - 01/2017
5Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2022 - 03/2012
4Amyloid Plaque
06/2022 - 01/2017
3Glioblastoma (Glioblastoma Multiforme)
11/2020 - 04/2014
2Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 01/2019
2Fibrosis (Cirrhosis)
01/2021 - 01/2021
2Breast Neoplasms (Breast Cancer)
06/2018 - 01/2007
2Neuroendocrine Tumors (Neuroendocrine Tumor)
01/2018 - 07/2014
2Colorectal Neoplasms (Colorectal Cancer)
09/2013 - 02/2012
1Cerebral Amyloid Angiopathy (Congophilic Angiopathy)
06/2022
1Radiation Fibrosis Syndrome (Radiation Fibrosis)
01/2021
1Sarcoma (Soft Tissue Sarcoma)
01/2021
1Pulmonary Fibrosis (Fibrosing Alveolitis)
01/2021
1Ventricular Tachycardia
01/2021
1Heart Failure
01/2021
1Starvation
12/2020
1Inflammation (Inflammations)
11/2020
1Lung Neoplasms (Lung Cancer)
01/2020
1Hypoxia (Hypoxemia)
01/2020
1Adenocarcinoma
01/2019
1Infections
01/2019
1Bacterial Infections (Bacterial Infection)
09/2017
1Glioma (Gliomas)
12/2016
1Ovarian Neoplasms (Ovarian Cancer)
01/2014

Drug/Important Bio-Agent (IBA)

16Peptides (Polypeptides)IBA
06/2022 - 02/2002
12BombesinIBA
06/2022 - 07/2003
9LigandsIBA
06/2022 - 01/2008
9Bombesin Receptors (Bombesin Receptor)IBA
06/2022 - 07/2003
5Chelating AgentsIBA
03/2022 - 04/2003
51,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
01/2022 - 07/2007
5Somatostatin Receptors (Somatostatin Receptor)IBA
07/2014 - 02/2002
4Radioisotopes (Radionuclides)IBA
06/2022 - 07/2007
3Amyloid (Amyloid Fibrils)IBA
06/2022 - 01/2021
3Biomarkers (Surrogate Marker)IBA
12/2020 - 03/2012
3Proteins (Proteins, Gene)FDA Link
01/2019 - 09/2013
3RadiopharmaceuticalsIBA
01/2017 - 01/2007
3Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
02/2012 - 05/2002
2CopperIBA
06/2022 - 09/2017
2IntegrinsIBA
01/2022 - 07/2018
2Chemokine ReceptorsIBA
01/2021 - 01/2020
2Indicators and Reagents (Reagents)IBA
01/2021 - 01/2019
2Amyloid beta-PeptidesIBA
12/2020 - 01/2017
2Copper-64IBA
07/2020 - 01/2018
2Glucose (Dextrose)FDA LinkGeneric
12/2016 - 01/2014
2Gastrin-Releasing PeptideIBA
04/2016 - 02/2015
2ErbB Receptors (EGF Receptor)IBA
09/2013 - 03/2004
2Monoclonal AntibodiesIBA
10/2005 - 04/2003
1benzothiazoleIBA
06/2022
1EstersIBA
01/2022
12-(4-hydroxyphenyl)benzothiazoleIBA
01/2022
1talazoparibIBA
05/2021
1VaccinesIBA
01/2021
1Bleomycin (Blenoxane)FDA LinkGeneric
01/2021
1distyrylbenzeneIBA
01/2021
1pirfenidoneIBA
01/2021
1Mutant Proteins (Protein, Mutant)IBA
01/2021
1Glycoproteins (Glycoprotein)IBA
01/2021
1Immunoglobulin FragmentsIBA
01/2021
1GlutaminaseIBA
12/2020
1Glutamine (L-Glutamine)FDA Link
12/2020
1Sulfhydryl Compounds (Thiols)IBA
12/2020
1Purine NucleosidesIBA
11/2020
1TritiumIBA
11/2020
1Nudix HydrolasesIBA
11/2020
1sphingosine 1-phosphate (sphingosine-1-phosphate)IBA
11/2020
1Phosphotransferases (Kinase)IBA
11/2020
1Adenosine Diphosphate (ADP)IBA
11/2020
1sphingosine kinaseIBA
11/2020
1Biological ProductsIBA
11/2020
1chenodeoxycholate sulfate conjugate (CDCS)IBA
01/2020
1NADP (NADPH)IBA
01/2020
1copper (II) diacetyl- di(N(4)- methylthiosemicarbazone)IBA
01/2020
1Pharmaceutical PreparationsIBA
01/2020
1Immunoglobulin M (IgM)IBA
01/2020
1beta-lapachoneIBA
01/2020
1Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
11/2018
1Poly (ADP-Ribose) Polymerase-1IBA
11/2018
1olaparibIBA
11/2018
1Trastuzumab (Herceptin)FDA Link
06/2018
1Silicon Dioxide (Silica)FDA LinkGeneric
01/2018
1peptide AIBA
12/2016
1Endoplasmic Reticulum Chaperone BiPIBA
12/2016
1Peptide Receptors (Peptide Receptor)IBA
04/2016
1Protease Inhibitors (Protease Inhibitor)IBA
04/2016
1phosphoramidonIBA
04/2016
1Transferrin (beta 2 Transferrin)IBA
01/2016
1Transferrin Receptors (Transferrin Receptor)IBA
01/2016
1Neuropeptide Receptors (Neuropeptide Receptor)IBA
02/2015
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
07/2014
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2014
1DNA (Deoxyribonucleic Acid)IBA
01/2014

Therapy/Procedure

18Therapeutics
06/2022 - 02/2002
7Radiotherapy
05/2021 - 02/2002
3Intravenous Injections
07/2018 - 02/2002
2Precision Medicine
06/2022 - 07/2018
2Immunotherapy
01/2021 - 01/2019
1Drug Therapy (Chemotherapy)
01/2020
1Aftercare (After-Treatment)
01/2020